Biotechnology Press Release
|03/25/2015 - 15:31||
Soft robotics expert receives NSF CAREER Award
Conor J. Walsh, assistant professor of mechanical and biomedical engineering at Harvard School of Engineering and Applied Sciences (SEAS) and a core faculty member at the Wyss Institute for Biologically Inspired Engineering at Harvard University, has been selected to receive a Faculty Early Career Development (CAREER) Award from the National Science Foundation (NSF). One of the most prestigious honors recognizing early-career scientists and engineers, the award will support Walsh’s research in the burgeoning field of soft wearable robotics.
|03/25/2015 - 09:14||
King's awarded £10m for world-leading Hub for Neuropsychiatry Imaging Research and Therapeutics
The Higher Education Funding Council for England (HEFCE) today pledged £10m towards a world-leading Hub for Neuropsychiatry Imaging Research and Therapeutics at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.
|03/25/2015 - 08:49||
BioLineRx Reports Successful Top-Line Safety and Efficacy Results for Novel Stem Cell Mobilization Treatment
All safety and efficacy endpoints were met, showing that treatment with BL-8040 as a single agent was safe and well tolerated at all doses and resulted in efficient stem cell mobilization and collection in all study participants. Importantly, the results support BL-8040 as one-day, single-dose collection regimen, which is a significant improvement upon the current standard of care.
|03/25/2015 - 03:23||
Osiris Therapeutics to Present at the 3rd Annual Regen Med Investor Day
COLUMBIA, Md.--( )-- Osiris Therapeutics, Inc.
|03/25/2015 - 01:34||
AstraZeneca to collaborate with the Harvard Stem Cell Institute in diabetes
AstraZeneca today announced that it has entered into a five-year research collaboration with the Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells for use in screens of AstraZeneca’s compound library in the search for new treatments for diabetes. The collaboration also aims to better understand how the function of beta cells declines in diabetes and research findings will be made available to the broader scientific community through peer-reviewed publications.
|03/24/2015 - 14:59||
RAYMOND JAMES CONTINUES BUILDING LIFE SCIENCES TEAM WITH KEY HIRES
ST. PETERSBURG, Fla. - Raymond James announced today the expansion of its Life Sciences practice with two key senior-level hires. Joining the firm’s Life Sciences Investment Banking team is banker Stuart Barich and Equity Capital Markets professional Edward Newman. Barich and Newman are managing directors and will provide a full range of investment banking advisory and capital raising solutions primarily in the biopharmaceuticals, biotechnology and pharmaceutical sectors.
|03/24/2015 - 13:43||
GMA Commends House Agriculture Hearing on Need for National Food Labeling Standards
WASHINGTON, DC – The Grocery Manufacturers Association praised the House Agriculture Committee for holding a hearing today examining the costs and impacts of mandatory biotechnology labeling laws.
|03/24/2015 - 12:44||
Kathy Giusti, Founder and Chairman of the Multiple Myeloma Research Foundation, to Deliver Keynote at MassBio Annual Meeting
Norwalk, Conn., March 24, 2015– Kathy Giusti, founder and Chairman of the Board of Directors of the Multiple Myeloma Research Foundation (MMRF) will deliver the keynote address at the 2015 MassBio Annual Meeting on Thursday, March 26, in Cambridge, Mass. Giusti’s address will focus on how collaborative research systems can inject speed and efficiency into the drug discovery and drug development process in order to get treatments to patients faster.
|03/24/2015 - 12:12||
BioClinica Opens Research Triangle Park Office
BioClinica®, Inc., a specialty clinical trials services and technology provider, today announced the opening of a Research Triangle Park (RTP) office in North Carolina in response to a rapidly expanding customer base of study sponsors and Clinical Research Organizations (CROs) with whom it has strategic partnerships.
|03/24/2015 - 10:21||
Dako, an Agilent Technologies Company, Announces Expanded Collaboration with Amgen Within Companion Diagnostics
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced a new Master Collaboration Agreement with Amgen Inc., a leading biotechnology company.
|03/24/2015 - 00:21||
SU2C and PBS LearningMedia Announce Award Program For Students In Conjunction with Film Supporters
March 24, 2015 (New York, NY) - Stand Up To Cancer (SU2C) and PBS LearningMedia announced today The EMPEROR Science Award Program, an initiative that will encourage students from disadvantaged high schools to pursue careers in science, with a particular emphasis on cancer research through a year of mentorship with a scientist from a leading research institution or industry. The education initiative, announced this morning by SU2C co-founder Katie Couric at Columbia University, is being launched in connection with Ken Burns Presents CANCER: THE EMPEROR OF ALL MALADIES a Film by Barak Goodman, a three-part film on the history of cancer that will air on PBS Monday, March 30, Tuesday, March 31 and Wednesday, April 1.
|Stand Up to Cancer|
|03/23/2015 - 22:53||
UMD To Celebrate Innovations and Partnerships
For University of Maryland researchers, the last year has marked a series of new discoveries and innovations: a revolutionary nanopore battery with high storage capabilities, a language aptitude measuring system, and a national food safety database to improve safety measures in retail establishments, to name just a few. UMD will honor nine nominees for the most promising new inventions at the Celebration of Innovation and Partnerships event on April 29.
|03/23/2015 - 21:38||
Catch-Release-Repeat. Study reveals novel technique for handling molecules
Like vast international trading companies, biological systems pick up freight items (in the form of small molecules), transport them from place to place and release them at their proper destination.
|03/23/2015 - 12:25||
University launches center for renewable energy
The University of Rochester is combining scholars, researchers, and resources from more than 15 academic departments and multiple schools to create the Center for Energy & Environment (CEE). Its purpose is to improve energy systems and to understand the impacts of energy technologies on the environment and human health.
|03/23/2015 - 10:44||
Halozyme Therapeutics Appoints James Mazzola To Lead Corporate Communications, Investor Relations
SAN DIEGO, March 23, 2015 / / -- Halozyme Therapeutics, Inc.
|03/23/2015 - 01:37||
Cardio3 BioSciences to open new manufacturing facility in Rochester, Minnesota (USA) to support phase III trial and US growth
Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development of engineered cell therapies, today confirmed plans to open a new U.S.-based manufacturing facility in Rochester, Minnesota. The facility will support the Company’s current and anticipated manufacturing needs in the United States for both the Phase III clinical trial evaluating lead cardiovascular product candidate C-Cure® (CHART-2), and its recently acquired CAR T-cell therapies’ portfolio. The facility will also serve as a base for the Company’s research and clinical collaboration with Mayo Clinic, also based in Rochester.
|03/23/2015 - 01:37||
Bone Therapeutics treats first patients in ALLOB® Phase IIA spinal fusion trial
BONE THERAPEUTICS, the bone cell therapy company addressing high unmet medical needs in the field of bone fracture repair and bone fracture prevention, today announces that the first four patients in the phase IIA proof-of-concept study for spinal fusion procedures have been treated with Bone Therapeutics’ allogeneic osteoblastic (bone-forming) cell therapy product, ALLOB®.
|03/20/2015 - 13:53||
Researchers in MIT Associate Professor
Krystyn J. Van Vliet's group last year showed that three biomechanical and biophysical markers could accurately identify the most desirable stem cells from a mixed group of bone marrow-derived cells. Now, MIT biological engineering graduate student Frances Liu is trying to advance that work by understanding how to alter the stem cells’ physical environment to get them to produce the most desirable chemical output.
|03/20/2015 - 11:23||
FDA concludes Arctic Apples and Innate Potatoes are safe for consumption
Today, the U.S. Food and Drug Administration completed its evaluation for two varieties of apples genetically engineered by Okanagan Specialty Fruits, Inc., and for six varieties of potatoes genetically engineered by J. R. Simplot Company and concluded that these foods are as safe and nutritious as their conventional counterparts.
|03/20/2015 - 05:09||
Mechanically stimulating stem cells
MIT biological engineering graduate student Frances Liu works with a spiral-shaped inertial microfluidic separation device for separating stem cell populations in the Laboratory for Material Chemomechanics at MIT. This device was adapted from previous designs to separate cells as a function of diameter. Liu also grows bone marrow-derived stem cells and studies how those stem cells release certain chemicals in response to mechanical interactions with materials in the surrounding environment.
|03/20/2015 - 00:25||
Accelerating Research Toward Cures
In addition to replacing lost or damaged tissue, stem cells are expected to accelerate drug discovery, drug screening and disease research. Find out how stem cells are used to help fast-track medical research.
|03/20/2015 - 00:25||
Where CIRM Funding Goes
California's Stem Cell Agency was created in 2004 when 59% of California voters approved Proposition 71: the California Stem Cell Research and Cures Initiative. That initiative created the California Institute for Regenerative Medicine (CIRM) to fund stem cell research in the state. In addition to creating the agency, Prop 71 created a 29-member governing Board composed of researchers, business leaders and patient advocates.
|03/20/2015 - 00:25||
The Power of Stem Cells
Stem cells have the potential to treat a wide range of diseases. Here, discover why these cells are such a powerful tool for treating disease—and what hurdles experts face before new therapies reach patients.
|03/20/2015 - 00:25||
From Lab Bench to Clinic Bedside
How do promising research breakthroughs lead to life-saving treatments? This guide will help you understand the complex path from bench to bedside.
|03/20/2015 - 00:25||
Creating New Types of Stem Cells
Generating new stem cell lines is a major focus of many CIRM-funded researchers. Learn why these new lines are considered so important as we accelerate discoveries from the lab bench to the patient’s bedside.